Psoriatic Arthritis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Children and teenagers aged 2 years old up to (but not including) 18 years old
- People whose doctor has decided to prescribe Xeljanz based on their medical judgement and in line with the approved prescribing guidelines
- People for whom Xeljanz has been prescribed according to its approved, labelled use for their condition
- People (and their legal guardian or representative, where applicable) who have been fully informed about the study and have signed and dated a consent form agreeing to take part
Who may not be able to join:
- Children or teenagers for whom Xeljanz is not recommended or is considered unsafe according to the most recently approved prescribing guidelines (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Pfizer CT.gov Call Center, Pfizer
Phone: 1-800-718-1021
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of patients with treatment emergent treatment-related adverse events
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.